DADC
NVAX icon

D.A. Davidson & Co’s Novavax NVAX Stock Holding History

D.A. Davidson & Co’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,458
Closed -$27K – 1105
2019
Q1 		$27K Hold
2,458
– – ﹤0.01% 1131
2018
Q4 		$90K Sell
2,458
-1,020
-29% -$39.5K ﹤0.01% 1058
2018
Q3 		$131K Buy
3,478
+250
+8% +$7.04K ﹤0.01% 1101
2018
Q2 		$86K Buy
3,228
+25
+0.8% +$845 ﹤0.01% 1093
2018
Q1 		$135K Sell
3,203
-480
-13% -$19.3K ﹤0.01% 1035
2017
Q4 		$91K Sell
3,683
-175
-5% -$4.27K ﹤0.01% 1086
2017
Q3 		$87K Buy
3,858
+200
+5% +$4.48K ﹤0.01% 1062
2017
Q2 		$84K Sell
3,658
-240
-6% -$4.71K ﹤0.01% 1343
2017
Q1 		$99K Sell
3,898
-355
-8% -$9.76K ﹤0.01% 1252
2016
Q4 		$107K Buy
4,253
+310
+8% +$9.04K ﹤0.01% 1273
2016
Q3 		$164K Buy
3,943
+1,415
+56% +$183K ﹤0.01% 1026
2016
Q2 		$367K Sell
2,528
-55
-2% -$6.3K 0.01% 642
2016
Q1 		$266K Buy
+2,583
New +$277K 0.01% 731
2014
Q3 		– Hold
0
– – – 2152
2014
Q2 		– Hold
0
– – – 2147
2014
Q1 		– Hold
0
– – – 2164
2013
Q4 		– Hold
0
– – – 2093

Other funds holding NVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

D.A. Davidson & Co's NVAX Position: Q2 2019 in Review

D.A. Davidson & Co sold out of Novavax (NVAX) in Q2 2019, closing a stake of 2,458 shares — an estimated $27K sold.

D.A. Davidson & Co first reported a position in NVAX in Q1 2016 and held it in 13 quarters. The position peaked at $367K in Q2 2016. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

  • D.A. Davidson & Co reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
  • D.A. Davidson & Co sold 2,458 Novavax shares in Q2 2019, an estimated $27K.
  • D.A. Davidson & Co first reported a position in Novavax in Q1 2016 and held it in 13 quarters.
  • D.A. Davidson & Co's Novavax position peaked at $367K in Q2 2016.
  • 81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on D.A. Davidson & Co's 13F filing for Q2 2019, filed 13 Aug 2019.